Due to its peptide structure and stability profile, BPC-157 is frequently studied in comparative peptide research involving signaling mechanisms and tissue-model experimental systems
The peptides were transported from the surface of the olfactory bulb or bottom region of the brain around the hypothalamus to the deeper part of the brain through the CSF or perivascular spaces of the cerebral artery ( Intranasal coadministration of noncovalently bound L-penetratin with insulin increased insulin levels in the brain and its pharmacological effects were tested at two differential stages of memory impairment using a senescence-accelerated mouse-prone 8 (SAMP8) model that exhibits spontaneous aging and senescence ( The investigators suggested that the phenomenon might occur due to the competition between insulin and A for the degradative pathway by insulin-degrading enzyme (IDE), an enzyme involved in the clearance of extracellular A from the brain ( 7.2 Nose-to-brain delivery of exendin-4 and insulin using penetratin Having established that intranasal insulin/L-penetratin administration was effective at mild stage of cognitive dysfunction but not at severe cognitive dysfunction in senescence-accelerated mice ( Intranasal coadministration of exendin-4 with L-penetratin but not with D-penetratin increased exendin-4 distribution throughout the various brain regions, including the olfactory bulb, the entry point for nose-to-brain delivery ( To test the therapeutic efficacy of nose-to-brain delivery of insulin with exendin-4, exendin-4 and L-penetratin were nasally administered for 30 days with or without insulin at a dose that is adequate to avoid A accumulation in SAMP8 mice ( in vivo
Freezing damages the peptide structure and reduces bioactivity
I havent lost anything at all
2014 An interactive 3D model rendered from the compound record rotate and explore its structure
Immunostaining was performed by seeding cells on glass coverslips, fixing with paraformaldehyde, permeabilizing with Triton X-100, and then incubating with primary anti-NF-B p65 antibody, followed by Alexa Fluor 546-conjugated secondary antibody
